{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:42:45Z","timestamp":1786718565874,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Androl"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/aja.aja_81_17","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T04:34:05Z","timestamp":1517891645000},"page":"324","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of PSA-age volume score in predicting prostate cancer in Chinese population"],"prefix":"10.4103","volume":"20","author":[{"given":"Rong","family":"Na","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Shuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Liang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Jun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Wen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Hua","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1008-682X.224774-1","first-page":"69\u201390","volume-title":"Global cancer statistics","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key-10.4103\/1008-682X.224774-2","first-page":"2893\u2013917","volume-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"key-10.4103\/1008-682X.224774-3","first-page":"177\u201380","volume-title":"Epidemiological trends of prostate cancer: retrospect and prospect","author":"Ye","year":"2007","journal-title":"China Oncol"},{"key":"key-10.4103\/1008-682X.224774-4","first-page":"60\u20137","volume-title":"International trends and patterns of prostate cancer incidence and mortality","author":"Hsing","year":"2000","journal-title":"Int J Cancer"},{"key":"key-10.4103\/1008-682X.224774-5","unstructured":"Na YQ, Ye ZQ, Sun YH, Sun G, Huang J, et al. Chinese Urological Association Guidelines 2014 Edition. Beijing: People's Medical Publishing House; 2014. p. 61. [Book in Chinese]."},{"key":"key-10.4103\/1008-682X.224774-6","first-page":"1156\u201361","volume-title":"Measurement of prostate-specific antigen in serum as a screening test for prostate cancer","author":"Catalona","year":"1991","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1008-682X.224774-7","first-page":"95\u2013101","volume-title":"Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma","author":"Mistry","year":"2003","journal-title":"J Am Board Fam Med"},{"key":"key-10.4103\/1008-682X.224774-8","first-page":"2427\u201334","volume-title":"Strategies combining total and percent free prostate specific antigen for detecting prostate cancer: a prospective evaluation","author":"Gann","year":"2002","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.224774-9","first-page":"451\u20136","volume-title":"Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in Hispanic-American and white men","author":"Lam","year":"2003","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.224774-10","first-page":"103\u201311","volume-title":"Preoperative serum prostate specific antigen levels between 2 and 22 ng\/ml.correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng\/ml","author":"Stamey","year":"2002","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.224774-11","first-page":"1264\u20137","volume-title":"The influence of prostate volume on prostate cancer detection using a combined approach of contrast-enhanced ultrasonography-targeted and systematic grey-scale biopsy","author":"Colleselli","year":"2007","journal-title":"BJU Int"},{"key":"key-10.4103\/1008-682X.224774-12","first-page":"860\u20134","volume-title":"Serum prostate-specific antigen in a community-based population of healthy men.Establishment of age-specific reference ranges","author":"Oesterling","year":"1993","journal-title":"JAMA"},{"key":"key-10.4103\/1008-682X.224774-13","first-page":"1090\u20135","volume-title":"Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios","author":"Oesterling","year":"1995","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.224774-14","first-page":"304\u201310","volume-title":"Age-specific reference ranges for prostate-specific antigen in black men","author":"Morgan","year":"1996","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1008-682X.224774-15","first-page":"482\u20136","volume-title":"The influence of prostate volume on cancer detection in the Chinese population","author":"Wu","year":"2014","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.224774-16","first-page":"e67585","volume-title":"Age-specific prostate specific antigen cutoffs for guiding biopsy decision in Chinese population","author":"Na","year":"2013","journal-title":"PLoS One"},{"key":"key-10.4103\/1008-682X.224774-17","first-page":"1361\u20135","volume-title":"Age-related free PSA, total PSA and free PSA\/total PSA ratios: establishment of reference ranges in Chinese males","author":"Kao","year":"1997","journal-title":"Anticancer Res"},{"key":"key-10.4103\/1008-682X.224774-18","first-page":"602\u20136","volume-title":"Evaluation of novel formula of PSA, age, prostate volume, and race in predicting positive prostate biopsy findings","author":"Patel","year":"2013","journal-title":"Urology"},{"key":"key-10.4103\/1008-682X.224774-19","first-page":"5365\u201370","volume-title":"Comparison of the formula of PSA, age, prostate volume and race versus PSA density and the detection of primary malignant circulating prostate cells in predicting a positive initial prostate biopsy in chilean men with suspicion of prostate cancer","author":"Murray","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"key-10.4103\/1008-682X.224774-20","first-page":"864\u20138","volume-title":"Assessment of PSA-age volume score in predicting positive prostate biopsy findings in Turkey","author":"Ucer","year":"2015","journal-title":"Int Braz J Urol"},{"key":"key-10.4103\/1008-682X.224774-21","first-page":"e49914","volume-title":"Outcomes and trends of prostate biopsy for prostate cancer in Chinese men from 2003 to 2011","author":"Na","year":"2012","journal-title":"PLoS One"},{"key":"key-10.4103\/1008-682X.224774-22","doi-asserted-by":"crossref","unstructured":"Bruno JJ, Armenakas NA, Fracchia JA. Influence of prostate volume and percent free prostate specific antigen on prostate cancer detection in men with a total prostate specific antigen of 2.6 to 10.0 ng\/ml. J Urol 2007; 177: 1741\u20134.","DOI":"10.1016\/j.juro.2007.01.067"},{"key":"key-10.4103\/1008-682X.224774-23","first-page":"3007\u201311","volume-title":"The prostate cancer prevention trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome","author":"Vickers","year":"2013","journal-title":"Cancer"},{"key":"key-10.4103\/1008-682X.224774-24","first-page":"1207\u201310","volume-title":"The use of prostate specific antigen (PSA) density in detecting prostate cancer in Chinese men with PSA levels of 4-10 ng\/mL","author":"Zheng","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"key-10.4103\/1008-682X.224774-25","doi-asserted-by":"crossref","unstructured":"Tang P, Du W, Xie K, Deng X, Fu J, et al. Transition zone PSA density improves the prostate cancer detection rate both in PSA 4.0-10.0 and 10.1-20.0 ng\/ml in Chinese men. Urol Oncol 2013; 31: 744\u20138.","DOI":"10.1016\/j.urolonc.2011.06.012"},{"key":"key-10.4103\/1008-682X.224774-26","first-page":"323\u201332","volume-title":"Prostate-specific antigen density","author":"Beduschi","year":"1997","journal-title":"Urol Clin North Am"},{"key":"key-10.4103\/1008-682X.224774-27","first-page":"948\u201354","volume-title":"Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening","author":"Catalona","year":"1993","journal-title":"JAMA"},{"key":"key-10.4103\/1008-682X.224774-28","doi-asserted-by":"crossref","unstructured":"Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002; 94: 981\u201390.","DOI":"10.1093\/jnci\/94.13.981"},{"key":"key-10.4103\/1008-682X.224774-29","first-page":"578\u201387","volume-title":"Prostate-specific antigen kinetics in localized and advanced prostate cancer","author":"Fitzpatrick","year":"2009","journal-title":"BJU Int"},{"key":"key-10.4103\/1008-682X.224774-30","first-page":"214\u201322","volume-title":"Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng\/ml: results of a prospective study in a clinical setting","author":"Guazzoni","year":"2011","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.224774-31","unstructured":"Lin YR, Wei XH, Uhlman M, Lin XT, Wu SF, et al. PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5-10.0 ng ml\u22121 and 10.1-20.0 ng ml\u22121: a multicenter study. Asian J Androl 2015; 17: 503\u20137."},{"key":"key-10.4103\/1008-682X.224774-32","first-page":"113\u20136","volume-title":"The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men","author":"Teoh","year":"2017","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.224774-33","first-page":"31384\u201392","volume-title":"Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression","author":"Stuchbery","year":"2016","journal-title":"Oncotarget"},{"key":"key-10.4103\/1008-682X.224774-34","first-page":"99\u2013104","volume-title":"Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population","author":"Chiu","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key-10.4103\/1008-682X.224774-35","first-page":"685\u201399","volume-title":"Application of the predictive value model in the analysis of test effectiveness","author":"Galen","year":"1982","journal-title":"Clin Lab Med"},{"key":"key-10.4103\/1008-682X.224774-36","first-page":"1569\u201375","volume-title":"Performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and the prostate health index (PHI) in a Chinese hospital-based biopsy population","author":"Na","year":"2014","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.224774-37","first-page":"181\u20137","volume-title":"Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group","author":"Ankerst","year":"2012","journal-title":"World J Urol"}],"container-title":["Asian Journal of Andrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:36:45Z","timestamp":1786714605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aja.aja_81_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"alternative-id":["224774"],"URL":"https:\/\/doi.org\/10.4103\/aja.aja_81_17","relation":{},"ISSN":["1008-682X"],"issn-type":[{"value":"1008-682X","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}